NASDAQ · Healthcare · Biotechnology
NovaBridge Biosciences
NBP
NovaBridge Biosciences, a biotech company, focuses on the development of immuno-oncology agents for the treatment of cancer in the United States. CEO Xi-Yong Fu · Market cap $236.9M.
$2.06
-0.01 · -0.24%
52w hi $6.7952w lo $0.85
Off 52w high 64.8%
72
NOTABLE
Current InsiderScore
Corp · 90d
1
1 buys · 0 sales
Cong · 90d
0
0 buys · 0 sales
Signals ≥ 60 · 12mo
1
0 strong · 1 notable
Analyst consensus
Strong Buy
Avg PT $9.00
Section 01
Recent Form 4 filings
1 filings on file
| Date | Insider | Role | Action | Shares | Price | Value | Score |
|---|---|---|---|---|---|---|---|
| Apr 24 | Mark Arnold Hagler | President and Chief Commercial Officer | Buy | 230,000 | $2.51 | +$577K | 72 |
Section 02
Recent STOCK Act disclosures
No disclosures yet
No STOCK Act disclosures on record for this ticker.
Section 03
InsiderScore history
Rolling 12 months · peak score per month
JunJulAugSepOctNovDecJanFebMarAprMay